110 related articles for article (PubMed ID: 19158836)
1. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.
Boyd EM; Bench AJ; Vaghela KJ; Campbell GN; Chowdhury FB; Gudgin EJ; Scott MA; Erber WN
Leukemia; 2009 Jun; 23(6):1164-7. PubMed ID: 19158836
[No Abstract] [Full Text] [Related]
2. Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13).
Fujiki A; Imamura T; Furutani A; Hatano W; Asai D; Hirashima Y; Miyachi M; Tamura S; Tsuchiya K; Iehara T; Ishida H; Yoshihara T; Hosoi H
J Pediatr Hematol Oncol; 2012 Jul; 34(5):402-5. PubMed ID: 22278196
[TBL] [Abstract][Full Text] [Related]
3. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.
Rozman M; Camós M; Colomer D; Villamor N; Esteve J; Costa D; Carrió A; Aymerich M; Aguilar JL; Domingo A; Solé F; Gomis F; Florensa L; Montserrat E; Campo E
Genes Chromosomes Cancer; 2004 Jun; 40(2):140-5. PubMed ID: 15101047
[TBL] [Abstract][Full Text] [Related]
4. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
Imamura T; Kakazu N; Hibi S; Morimoto A; Fukushima Y; Ijuin I; Hada S; Kitabayashi I; Abe T; Imashuku S
Genes Chromosomes Cancer; 2003 Apr; 36(4):413-9. PubMed ID: 12619166
[TBL] [Abstract][Full Text] [Related]
6. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous remission of adult acute myeloid leukemia with t(8;16)(p11;p13)/MOZ-CBP fusion.
Hoshino T; Taki T; Takada S; Hatsumi N; Sakura T
Leuk Lymphoma; 2018 Jan; 59(1):253-255. PubMed ID: 28535725
[No Abstract] [Full Text] [Related]
8. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
Schnittger S; Bacher U; Kern W; Haferlach C; Haferlach T
Leukemia; 2007 Jan; 21(1):183-4. PubMed ID: 17096014
[No Abstract] [Full Text] [Related]
9. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
[TBL] [Abstract][Full Text] [Related]
10. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation.
Crowley JA; Wang Y; Rapoport AP; Ning Y
Leukemia; 2005 Dec; 19(12):2344-5. PubMed ID: 16193081
[No Abstract] [Full Text] [Related]
11. A Long-term Survivor after Congenital Acute Myeloid Leukemia with t(8 ; 16)(p11 ; p13).
Hanada T; Kanamitsu K; Chayama K; Miyamura T; Kanazawa Y; Muraoka M; Washio K; Imada M; Kageyama M; Takeuchi A; Tamai K; Oda M; Shimada A
Acta Med Okayama; 2016; 70(1):31-5. PubMed ID: 26899607
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
[TBL] [Abstract][Full Text] [Related]
13. RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
Panagopoulos I; Fioretos T; Isaksson M; Mitelman F; Johansson B; Theorin N; Juliusson G
Genes Chromosomes Cancer; 2002 Dec; 35(4):372-4. PubMed ID: 12378533
[No Abstract] [Full Text] [Related]
14. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
Schmidt HH
Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
[No Abstract] [Full Text] [Related]
15. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
[TBL] [Abstract][Full Text] [Related]
16. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
[TBL] [Abstract][Full Text] [Related]
17. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).
Chaffanet M; Mozziconacci MJ; Fernandez F; Sainty D; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Genes Chromosomes Cancer; 1999 Oct; 26(2):161-5. PubMed ID: 10469454
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
19. Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics.
Kim J; Park TS; Song J; Lee KA; Hong DJ; Min YH; Cheong JW; Choi JR
Cancer Genet Cytogenet; 2009 Oct; 194(2):111-8. PubMed ID: 19781443
[TBL] [Abstract][Full Text] [Related]
20. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
